Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Zelnorm labeling updated with new risk information

May 5, 2004

Latest Rapinex NDA filing accepted for review

May 3, 2004

ATI-7505 enters clinic

May 3, 2004

New data on the efficacy of pegylated interferon alfa-2b in viral hepatitis

April 29, 2004

Therapeutic benefits of Pegasys plus ribavirin in HCV-infected patients

April 28, 2004

A preclinical trial suggests that histamine protects the liver against LPS-induced damage

April 28, 2004

Potential benefits reported for tacrolimus in fulminant hepatic failure

April 27, 2004

Novel caspase inhibitor against hepatocellular apoptosis

April 27, 2004

HepeX-C shows efficacy in preventing HCV reinfection

April 27, 2004

Japanese approval sought for Peg-Intron plus Rebetol for chronic hepatitis C

April 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...